Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Eleanor M. Wilson, Elana S. Rosenthal, Sarah Kattakuzhy, Lydia Tang & Shyam Kottilil. (2017) Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C. Clinical Microbiology Reviews 30:1, pages 23-42.
Crossref
Crossref
Sajjad Ullah, Habib U. Rehman & Muhammad Idrees. (2013) Mutations in the NS5A gene are associated with response to interferon+ribavirin combination therapy in patients with chronic hepatitis C virus 3a infection. European Journal of Gastroenterology & Hepatology, pages 1.
Crossref
Crossref
Gábor Gazdag, Gergely Horváth, Olga Szabó & Gabor S. Ungvari. (2011) Difficulties with interferon treatment in former intravenous drug users. The Brazilian Journal of Infectious Diseases 15:2, pages 163-166.
Crossref
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. (2010) Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jean‐Michel Pawlotsky. 2005. Viral Hepatitis. Viral Hepatitis
755
768
.
Isabelle Desombere, Hans Van Vlierberghe, Sibyl Couvent, Filip Clinckspoor & Geert Leroux-Roels. (2005) Comparison of Qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2.0 versus VERSANT HCV RNA 3.0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatment of HCV Infections. Journal of Clinical Microbiology 43:6, pages 2590-2597.
Crossref
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Akihito Tsubota, Yasuji Arase, Takashi Someya, Yoshiyuki Suzuki, Fumitaka Suzuki, Satoshi Saitoh, Kenji Ikeda, Norio Akuta, Tetsuya Hosaka, Masahiro Kobayashi & Hiromitsu Kumada. (2004) Early viral kinetics and treatment outcome in combination of high‐dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load. Journal of Medical Virology 75:1, pages 27-34.
Crossref
Crossref
Alexander C. Haushofer & Harald H. Kessler. 2004. Encyclopedia of Medical Genomics and Proteomics. Encyclopedia of Medical Genomics and Proteomics
579
583
.
Linda Cook, Ka-Wing Ng, Arthur Bagabag, Lawrence Corey & Keith R. Jerome. (2004) Use of the MagNA Pure LC Automated Nucleic Acid Extraction System followed by Real-Time Reverse Transcription-PCR for Ultrasensitive Quantitation of Hepatitis C Virus RNA. Journal of Clinical Microbiology 42:9, pages 4130-4136.
Crossref
Crossref
Jean-Michel Pawlotsky. (2003) Use and interpretation of hepatitis C virus diagnostic assays. Clinics in Liver Disease 7:1, pages 127-137.
Crossref
Crossref
Jean-Michel Pawlotsky. (2002) Use and interpretation of virological tests for hepatitis C. Hepatology 36:5B, pages s65-s73.
Crossref
Crossref
Jean-Michel Pawlotsky. (2002) Use and interpretation of virological tests for hepatitis C. Hepatology 36:S1, pages S65-S73.
Crossref
Crossref
Ayaz M Majid & David R Gretch. (2002) Current and future hepatitis C virus diagnostic testing: problems and advancements. Microbes and Infection 4:12, pages 1227-1236.
Crossref
Crossref
Jean–Michel Pawlotsky. (2002) Molecular diagnosis of viral hepatitis. Gastroenterology 122:6, pages 1554-1568.
Crossref
Crossref
Lise Lotte Gluud, Kim Krogsgaard & Christian Gluud. (2002) Ribavirin with or without alpha interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Crossref
Eric Q. Konnick, Maria Erali, Edward R. Ashwood & David R. Hillyard. (2002) Performance Characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit Assay and the National Genetics Institute HCV Superquant Assay. Journal of Clinical Microbiology 40:3, pages 768-773.
Crossref
Crossref
R.S Ross, S Viazov, S Sarr, S Hoffmann, A Kramer & M Roggendorf. (2002) Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. Journal of Virological Methods 101:1-2, pages 159-168.
Crossref
Crossref
Vincent G. Bain. (2001) Effect of HCV viral dynamics on treatment design: lessons learned from HIV. The American Journal of Gastroenterology 96:10, pages 2818-2828.
Crossref
Crossref
Emilia Hadziyannis, Alexandros Hadziyannis, Belinda Yen-Lieberman, Michelle L. Kiwi, Sandra Hodnick, Fotini Spanou, Colleen Starkey & Zobair M. Younossi. (2001) Hepatitis C Virus RNA Assays. Journal of Clinical Gastroenterology 33:1, pages 45-48.
Crossref
Crossref
Michael E. de Vera, Gregory A. Smallwood, Kathia Rosado, Laurel Davis, Enrique Martinez, Shobha Sharma, Andrei C. Stieber & Thomas G. Heffron. (2001) INTERFERON-?? AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION1. Transplantation 71:5, pages 678-686.
Crossref
Crossref
Sung C. Lee, Anisha Antony, Nitta Lee, Jeff Leibow, Jian Q. Yang, Stephen Soviero, Karen Gutekunst & Maurice Rosenstraus. (2000) Improved Version 2.0 Qualitative and Quantitative AMPLICOR Reverse Transcription-PCR Tests for Hepatitis C Virus RNA: Calibration to International Units, Enhanced Genotype Reactivity, and Performance Characteristics. Journal of Clinical Microbiology 38:11, pages 4171-4179.
Crossref
Crossref
Laura Chandler. (2000) Diagnostic tests for hepatitis C virus. Clinical Microbiology Newsletter 22:19, pages 145-149.
Crossref
Crossref
Joerg Kleiber, Thomas Walter, Gerd Haberhausen, Sue Tsang, Reiner Babiel & Maurice Rosenstraus. (2000) Performance Characteristics of a Quantitative, Homogeneous TaqMan RT-PCR Test for HCV RNA. The Journal of Molecular Diagnostics 2:3, pages 158-166.
Crossref
Crossref
David Gretch. (2000) Standardization of hepatitis C virus-RNA quantification: Advances and unfinished business. Hepatology 31:3, pages 788-789.
Crossref
Crossref
Wolfgang T. Hofgärtner, Jeffrey A. Kant & Karen E. Weck. (2000) Hepatitis C Virus Quantitation: Optimization of Strategies for Detecting Low-Level Viremia. Journal of Clinical Microbiology 38:2, pages 888-891.
Crossref
Crossref
P. Halfon & P. Cacoub. (2000) Quantification virale du virus de l'hépatite C : présent et avenir. La Revue de Médecine Interne 21:2, pages 174-181.
Crossref
Crossref
Chihiro Morishima & David R. Gretch. (1999) CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY. Clinics in Liver Disease 3:4, pages 717-740.
Crossref
Crossref
Calogero Cammà, Marco Giunta, Liliana Chemello, Alfredo Alberti, Hidenori Toyoda, Christian Trepo, Patrick Marcellin, Friederike Zahm, Solko Schalm & Antonio Craxì. (1999) Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data. Hepatology 30:3, pages 801-807.
Crossref
Crossref